Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ciucci

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|February 11, 2014
Gimap and T cells: a matter of life or deathThomas Ciucci, Rémy Bosselut
European Journal of Immunology|February 6, 2016
A long journey coming to fruition: In sight of the preselection T-cell repertoireThomas Ciucci, Rémy Bosselut
Nature Immunology|November 14, 2018
TCF-1 takes HEB up a NotchChristelle Harly, Thomas Ciucci
Nature Immunology|May 21, 2014
A ROG(ue) in charge of the (natural) killersThomas Ciucci, Rémy Bosselut
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2015
200 Million Thymocytes and I: A Beginner's Survival Guide to T Cell DevelopmentMelanie S Vacchio, Thomas Ciucci, Rémy Bosselut
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2017
A STAT3-dependent transcriptional circuitry inhibits cytotoxic gene expression in T cellsThomas Ciucci, Melanie S Vacchio, Rémy Bosselut
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2015
Genetic Tools to Study T Cell DevelopmentThomas Ciucci, Melanie S Vacchio, Rémy Bosselut
Science Immunology|October 14, 2021
Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunitySarah Sanchez, Nicole Palacio, Tanushree Dangi, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunitySarah Sanchez, Nicole Palacio, Tanushree Dangi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2010
Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillanceSéverine Augier, Thomas Ciucci, Carmelo Luci, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|February 11, 2014
Gimap and T cells: a matter of life or deathThomas Ciucci, Rémy Bosselut
European Journal of Immunology|February 6, 2016
A long journey coming to fruition: In sight of the preselection T-cell repertoireThomas Ciucci, Rémy Bosselut
Nature Immunology|November 14, 2018
TCF-1 takes HEB up a NotchChristelle Harly, Thomas Ciucci
Nature Immunology|May 21, 2014
A ROG(ue) in charge of the (natural) killersThomas Ciucci, Rémy Bosselut
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2015
200 Million Thymocytes and I: A Beginner's Survival Guide to T Cell DevelopmentMelanie S Vacchio, Thomas Ciucci, Rémy Bosselut
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2017
A STAT3-dependent transcriptional circuitry inhibits cytotoxic gene expression in T cellsThomas Ciucci, Melanie S Vacchio, Rémy Bosselut
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2015
Genetic Tools to Study T Cell DevelopmentThomas Ciucci, Melanie S Vacchio, Rémy Bosselut
Science Immunology|October 14, 2021
Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunitySarah Sanchez, Nicole Palacio, Tanushree Dangi, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunitySarah Sanchez, Nicole Palacio, Tanushree Dangi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2010
Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillanceSéverine Augier, Thomas Ciucci, Carmelo Luci, et al.
Pageof 3